Search
for
Sort by
Research 181–210 of 1000+
- Treatment options for alopecia: an update, looking to the future
- Leydig Cell Hyperplasia and Adenomas in Mice Treated with Finasteride, a 5α-Reductase Inhibitor: A Possible Mechanism
- Dermal and Transdermal Drug Delivery through Vesicles and Particles: Preparation and Applications
- Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date
- Acne in women
- Androgen Receptor Accelerates Premature Senescence of Human Dermal Papilla Cells in Association with DNA Damage
- A Review of hormone-based therapies to treat adult acne vulgaris in women
- Gender-Affirming Hormone Therapy for Transgender Men
- Androgen antagonists in androgen target tissues
- Hormonal and Surgical Treatment Options for Transgender Men (Female-to-Male)
- Alterations in Hair Follicle Dynamics in Women
- Intraovarian vascular enhancement via stromal injection of platelet-derived growth factors: Exploring subsequent oocyte chromosomal status and in vitro fertilization outcomes
- Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients
- A missing piece: the spiny mouse and the puzzle of menstruating species
- Retinoid-mediated stimulation of steroid sulfatase activity in myeloid leukemic cell lines requires RARα and RXR and involves the phosphoinositide 3-kinase and ERK-MAP kinase pathways
- Venous thromboembolism and women's health
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Newborn infant skin gene expression: Remarkable differences versus adults
- Androgens modulate keratinocyte differentiation indirectly through enhancing growth factor production from dermal fibroblasts
- Androgenetic alopecia; drug safety and therapeutic strategies
- Dermal-epidermal interactions—follicle-derived cell populations in the study of hair-growth mechanisms
- Hair regrowth in a male patient with extensive androgenetic alopecia on estrogen therapy
- Chapter 17. Selective androgen receptor modulators (SARMs)
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
- Transferosomes: Unique vesicular carriers for effective transdermal delivery
- The Optimal Indication for Testosterone Replacement Therapy in Late Onset Hypogonadism
- Evaluation and Treatment of Gender Dysphoria to Prepare for Gender Confirmation Surgery
- Niosomes as Carrier in Dermal Drug Delivery
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Effects of pre- and post-pubertal dihydrotestosterone treatment on penile length in 5α-reductase type 2 deficiency